Literature DB >> 31296776

Comparison of Cardiovascular Outcomes by Dialysis Modality: A Systematic Review and Meta-Analysis.

Matthew R Lozier1, Alexandra M Sanchez2, John J Lee3, Leonardo J Tamariz4, Gabriel A Valle4,5.   

Abstract

Debates exist regarding the merit of starting one dialysis modality over the other for improved cardiovascular outcomes. Five previously published prospective and retrospective cohort studies have reported inconsistent conclusions on this topic. The aim of this systematic review and meta-analysis is to evaluate the influence initiation of hemodialysis (HD) vs peritoneal dialysis (PD) may have on the relative risk (RR) of subsequent development of adverse cardiovascular events (ACVE) in patients with end-stage renal disease (ESRD). Of the 518 records identified, 5 cohort studies, assessing a total of 47,062 patients were included in the meta-analysis. With regard to the subsequent development of ACVE following initiation on the different dialysis modalities, the pooled RR was found to be non-significant. Peritoneal dialysis is a suitable and cost-effective alternative to HD for ESRD patients at risk of cardiovascular disease.
Copyright © 2019 International Society for Peritoneal Dialysis.

Entities:  

Keywords:  Renal replacement therapy; adverse cardiovascular events; hyper-dynamic flow; metabolic syndrome; pharmaco-therapeutic; residual renal function

Mesh:

Year:  2019        PMID: 31296776     DOI: 10.3747/pdi.2018.00227

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  3 in total

1.  Increased miR-7641 Levels in Peritoneal Hyalinizing Vasculopathy in Long-Term Peritoneal Dialysis Patients.

Authors:  Raquel Díaz; Pilar Sandoval; Raul R Rodrigues-Diez; Gloria Del Peso; José A Jiménez-Heffernan; Ricardo Ramos-Ruíz; Carlos Llorens; Gustavo Laham; Mabel Alvarez-Quiroga; Manuel López-Cabrera; Marta Ruiz-Ortega; María A Bajo; Rafael Selgas
Journal:  Int J Mol Sci       Date:  2020-08-13       Impact factor: 5.923

2.  Challenges for Peritoneal Dialysis Centers Before and During the COVID-19 Pandemic in Mexico.

Authors:  Diana Perez-Moran; Ricardo Perez-Cuevas; Svetlana V Doubova
Journal:  Arch Med Res       Date:  2022-04-29       Impact factor: 8.323

3.  Scope and heterogeneity of outcomes reported in randomized trials in patients receiving peritoneal dialysis.

Authors:  Karine E Manera; David W Johnson; Yeoungjee Cho; Benedicte Sautenet; Jenny Shen; Ayano Kelly; Angela Yee-Moon Wang; Edwina A Brown; Gillian Brunier; Jeffrey Perl; Jie Dong; Martin Wilkie; Rajnish Mehrotra; Roberto Pecoits-Filho; Saraladevi Naicker; Tony Dunning; Jonathan C Craig; Allison Tong
Journal:  Clin Kidney J       Date:  2020-12-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.